Biotechnologies Available for Licensing
Click on Tech ID # link for detailed information. Available biotechnologies may also be viewed by type and application here.
in vivo data available
|
Adenosine A2A Receptor: A Prognosis Marker for Lung Cancer
|
08-11
|
|
Novel Phospholipid-Based TLR Inhibitors
|
07-07
|
| Targeting VGamma4 T Cells to treat rheumatoid arthritis and other autoimmune diseases |
07-06
|
|
Knee aspirate facilitator
|
07-02
|
|
A novel histone demethylase and its 3-D structure
|
06-08
|
| MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo |
06-05
|
| The secreted protein Fibulin-3: anti-angiogenic factor |
05-01
|
|
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.)
Invention Awarded a "Proof of Concept" Grant from the State of Colorado
|
04-08
|
|
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases
|
04-05
|
|
Be-Adducts and 10Be-Adduct Probes in the Diagnosis and Treatment of Disease
|
04-03
|
|
Method for identifying MHC-presented epitopes for T cells
|
03-01
|
|
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancer
Invention Awarded a "Proof of Concept" Grant from the State of Colorado
|
02-16
|
|
Efficient method to produce mature neutrophils from embryonic stem cells
|
02-08
|
|
Liposomal clodronate as a therapy for autoimmune hemolytic anemia
|
02-07
|
|
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway
|
02-05
|
|
Use of soluble gamma/delta T cell receptor as a therapy for inflammatory diseases and cancer
Invention Awarded a "Proof of Concept" Grant from the State of Colorado
|
02-03
|
|
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsiveness
Invention Awarded a "Proof of Concept" Grant from the State of Colorado
|
01-01
|
|
Cdk6 as a marker for breast cancer
|
00-11
|
|
Solid inexpensive culture medium for testing susceptibility to tuberculosis drugs
|
00-05
|
|
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure
|
00-01
|
|
Method for treating inflammatory diseases using heat shock proteins
Invention Awarded a "Proof of Concept" Grant from the State of Colorado
|
98-07
|
|
Anti-CD79 antibody offers novel approach to therapy in autoimmune disease, transplantation and lymphoma
|
98-04
|
|
Compositions and targets for specific modulation of cytokine isotypes associated with differential effects on airway function and fibrosis
|
97-08
|
|
Thioredoxins for the treatment of lung disease
|
96-07
|
|
Product and process to regulate actin polymerization
|
96-06
|
|
Method for T lymphocyte immunosupression
|
96-04
|
|
Peptides offer strategies for novel immunosuppressants and anti-herpes agents
|
96-02
|
|
Interleukin-12 based therapy for inflammatory diseases
|
95-05
|
|
Promising gene immunotherapy technology fights tumors and infectious diseases
|
95-03
|
|
Antibody product and method targets antigenic peptides to antigen presenting cells for desired immune responses
|
95-01
|
|
Molecular method for diagnosing steroid resistance
|
94-03
|
|
Process for producing monoclonal antibodies against human T cell receptor elements
|
91-02
|
Research Tools
See list of available
Antibodies or
Animal models.
Biomedical Devices
See
list of available biomedical devices.
For more information, contact Emmanuel Hilaire at hilairee@njc.org.
